Get educated about hair loss. Use this section to learn about the various different types of alopecia, what is known about their causes the mechanisms behind them.
Alpha-Linoleic Acid (ALA): Inhibitory effect of fatty acids on the binding of androgen receptor and R1881.
Alpha-Linoleic Acid (ALA): Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
Avodart (Dutasteride): Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride.
Broccoli: Chemical in Broccoli Blocks Growth of Prostate Cancer Cells, New Study Shows
Broccoli: Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
Broccoli: Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells.
Cyclosporin: Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice.
Fluridil: Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience.
Gamma-Linoleic Acid (GLA): Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
Gamma-Linoleic Acid (GLA): Inhibitory effect of fatty acids on the binding of androgen receptor and R1881.
Gamma-Linoleic Acid (GLA): Growth suppression of hamster flank organs by topical application of gamma-linolenic and other fatty acid inhibitors of 5alpha-reductase.
Green Tea Catechins: Suppression of Human Pancreatic Carcinoma Cell Growth and Invasion by Epigallocatechin-3-Gallate.
Green Tea Catechins: Green tea as a potent antioxidant in alcohol intoxication.
Green Tea Catechins: Green tea and prostate cancer.
Green Tea Catechins: Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate.
KF19418: KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models.
Latanoprost: Prostaglandin-Induced Hair Growth.
Latanoprost: Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot study.
Latanoprost: Eyelash hypertrichosis in a patient treated with topical latanoprost.
Linoleic Acid (LA): Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
Linoleic Acid (LA): Inhibitory effect of fatty acids on the binding of androgen receptor and R1881.
Liposomes: Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles.
Lipoxidil: Male pattern baldness.
Lipoxidil: Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
Lipoxidil: Enhanced in vitro hair growth at the air-liquid interface: minoxidil preserves the root sheath in cultured whisker follicles.
Lipoxidil: Hair growth effect of minoxidil
Lipoxidil: Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects?
Lipoxidil: Minoxidil stimulates mouse vibrissae follicles in organ culture.
Lipoxidil: Minoxidil sulfate is the active metabolite that stimulates hair follicles.
Lipoxidil: Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo.
Lipoxidil: Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles.
Lipoxidil: A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Lipoxidil: A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lipoxidil: Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Lipoxidil: Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Lipoxidil: An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia
Nizoral (Ketoconazole): Ketoconazole shampoo: effect of long-term use in androgenic alopecia.
Nizoral (Ketoconazole): Ketoconazole binds to the human androgen receptor.
Oleic Acid: Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
Oleic Acid: Inhibitory effect of fatty acids on the binding of androgen receptor and R1881.
Propecia (Finasteride) (also known as proscar for BPH): Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
Propecia (Finasteride) (also known as proscar for BPH): An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia
Propecia (Finasteride) (also known as proscar for BPH): Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia
Propecia (Finasteride) (also known as proscar for BPH): Male pattern baldness.
Propecia (Finasteride) (also known as proscar for BPH): Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
Retin-A (Tretinoin): Topical tretinoin for hair growth promotion.
Revivogen: Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
Revivogen: Growth suppression of hamster flank organs by topical application of gamma-linolenic and other fatty acid inhibitors of 5alpha-reductase.
Revivogen: Inhibitory effect of fatty acids on the binding of androgen receptor and R1881.
Rogaine (Minoxidil) (also known as Loniten when taken internally): Minoxidil stimulates mouse vibrissae follicles in organ culture.
Rogaine (Minoxidil) (also known as Loniten when taken internally): Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Rogaine (Minoxidil) (also known as Loniten when taken internally): A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Rogaine (Minoxidil) (also known as Loniten when taken internally): Minoxidil sulfate is the active metabolite that stimulates hair follicles.
Rogaine (Minoxidil) (also known as Loniten when taken internally): Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo.
Rogaine (Minoxidil) (also known as Loniten when taken internally): Enhanced in vitro hair growth at the air-liquid interface: minoxidil preserves the root sheath in cultured whisker follicles.
Rogaine (Minoxidil) (also known as Loniten when taken internally): Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
Rogaine (Minoxidil) (also known as Loniten when taken internally): A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Rogaine (Minoxidil) (also known as Loniten when taken internally): An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia
Rogaine (Minoxidil) (also known as Loniten when taken internally): Hair growth effect of minoxidil
Rogaine (Minoxidil) (also known as Loniten when taken internally): Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Rogaine (Minoxidil) (also known as Loniten when taken internally): Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects?
Rogaine (Minoxidil) (also known as Loniten when taken internally): Male pattern baldness.
Xandrox 12.5% Lotion: Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
Xandrox 12.5% Lotion: Enhanced in vitro hair growth at the air-liquid interface: minoxidil preserves the root sheath in cultured whisker follicles.
Xandrox 12.5% Lotion: Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo.
Xandrox 12.5% Lotion: Minoxidil sulfate is the active metabolite that stimulates hair follicles.
Xandrox 12.5% Lotion: Minoxidil stimulates mouse vibrissae follicles in organ culture.
Xandrox 12.5% Lotion: Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Xandrox 12.5% Lotion: Male pattern baldness.
Xandrox 12.5% Lotion: Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects?
Xandrox 12.5% Lotion: Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Xandrox 12.5% Lotion: Hair growth effect of minoxidil
Xandrox 5% day-time solution: Hair growth effect of minoxidil
Xandrox 5% day-time solution: Minoxidil stimulates mouse vibrissae follicles in organ culture.
Xandrox 5% day-time solution: Enhanced in vitro hair growth at the air-liquid interface: minoxidil preserves the root sheath in cultured whisker follicles.
Xandrox 5% day-time solution: Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects?
Xandrox 5% day-time solution: Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo.
Xandrox 5% day-time solution: Male pattern baldness.
Xandrox 5% day-time solution: Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
Xandrox 5% day-time solution: Minoxidil sulfate is the active metabolite that stimulates hair follicles.
Xandrox 5% day-time solution: Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Xandrox 5% day-time solution: Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Xandrox 5% night-time solution: Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects?
Xandrox 5% night-time solution: Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Xandrox 5% night-time solution: Minoxidil stimulates mouse vibrissae follicles in organ culture.
Xandrox 5% night-time solution: Minoxidil sulfate is the active metabolite that stimulates hair follicles.
Xandrox 5% night-time solution: Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo.
Xandrox 5% night-time solution: Enhanced in vitro hair growth at the air-liquid interface: minoxidil preserves the root sheath in cultured whisker follicles.
Xandrox 5% night-time solution: Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
Xandrox 5% night-time solution: Hair growth effect of minoxidil
Xandrox 5% night-time solution: Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Xandrox 5% night-time solution: Male pattern baldness.
